Inhalable siRNA Nanoparticles for Enhanced Tumor-Targeting Treatment of KRAS-Mutant Non-Small-Cell Lung Cancer

Keyphrases

• Targeted Treatment 100%
• Tumor Targeting 100%
• Kirsten Rat Sarcoma 100%
• Inhalable 100%
• SiRNA Nanoparticle 100%
• Non-small Cell Lung Cancer (NSCLC) 100%
• Tumor 33%
• Gene Therapy 33%
• Lung 33%
• Adverse Effects 16%
• Respiratory Disease 16%
• Nanoparticle Systems 16%
• Targeting Capability 16%
• Cancer Treatment 16%
• Lung Cancer 16%
• Structural Integrity 16%
• Knockdown 16%
• Oncogene 16%
• Systemic Administration 16%
• Therapy Approaches 16%
• Lung Toxicity 16%
• Treatment Modalities 16%
• Systemic Toxicity 16%
• Orthotopic Model 16%
• Aerosol Inhalation 16%
• Inhaled Gene Therapy 16%
• Systemic Delivery 16%
• Delivery Approaches 16%
• Biosafety 16%
• Lung-other 16%
• Enhanced Antitumor Activity 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Neoplasm 100%
• Nanoparticle 100%
• Small Interfering RNA 100%
• Sarcoma 100%
• Non Small Cell Lung Cancer 100%
• Malignant Neoplasm 16%
• Mouse Model 16%
• Adverse Event 16%
• Lung Cancer 16%
• Systemic Administration 16%
• Respiratory Tract Disease 16%
• Antitumor Activity 16%